Stock & Company Details
Cadrenal Therapeutics Inc $CVKD
Price:
N/A
N/A
3.6M
$3.3M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.16
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
CVKD technical indicators
Latest Cadrenal Therapeutics Inc (CVKD) indicator readings as of 2026-10-09.
CVKD's 14-day RSI is 30.6, in neutral territory. At $0.91 it is trading 79.5% below its 200-day moving average of $4.44, and below its 50-day average of $1.41. Price sits near the lower Bollinger Band ($0.86 to $1.26). ADX reads 14.1, indicating a range-bound market rather than a trend.
Overview
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
Finance Bot
Ask your questions
Start by typing a question below.
